MyFinsight
Home
Blog
About
Cash and cash
equivalents
$54,980K
(41.98%↑ Y/Y)
Accounts receivable, net
$29,871K
(-9.29%↓ Y/Y)
Investments
$10,125K
(-21.95%↓ Y/Y)
Prepaid expenses and
other current assets
$7,408K
(-10.20%↓ Y/Y)
Inventory
$3,994K
(-19.99%↓ Y/Y)
Total current assets
$106,378K
(8.69%↑ Y/Y)
Operating lease
right-of-use assets
$4,260K
(-16.16%↓ Y/Y)
Restricted cash
$318K
(-9.14%↓ Y/Y)
Other assets
$267K
(-79.99%↓ Y/Y)
Property and equipment,
net
$94K
(-61.48%↓ Y/Y)
Total assets
$111,317K
(6.14%↑ Y/Y)
Accumulated deficit
-$1,848,914K
(-13.84%↓ Y/Y)
Total liabilities and
stockholders' deficit
$111,317K
(6.14%↑ Y/Y)
Total stockholders'
deficit
-$330,168K
(-38.19%↓ Y/Y)
Additional paid-in capital
$1,518,691K
(9.61%↑ Y/Y)
Accumulated other
comprehensive income
$41K
(116.33%↑ Y/Y)
Common stock, 0.0001
par value 106,000...
$14K
(7.69%↑ Y/Y)
Total liabilities
$441,485K
(28.41%↑ Y/Y)
Total current
liabilities
$134,233K
(35.29%↑ Y/Y)
Convertible senior notes due
2029
$98,650K
(57.38%↑ Y/Y)
Senior secured term
loan, net of current...
$85,047K
(-5.05%↓ Y/Y)
Deferred royalty
obligation
$72,338K
(-1.58%↓ Y/Y)
Convertible senior notes due
2028
$25,937K
Common stock warrants
$19,761K
(356.06%↑ Y/Y)
Operating lease
liabilities, net of current...
$5,183K
(-17.09%↓ Y/Y)
Other liabilities
$336K
(-95.93%↓ Y/Y)
Accrued expenses
$78,804K
(25.23%↑ Y/Y)
Senior secured term
loan
$40,307K
(544.91%↑ Y/Y)
Accounts payable
$7,660K
(194.96%↑ Y/Y)
Other current
liabilities
$6,394K
(306.48%↑ Y/Y)
Operating lease
liabilities
$1,068K
(-22.78%↓ Y/Y)
Back
Back
Balance Sheet
Karyopharm Therapeutics Inc. (KPTI)
Karyopharm Therapeutics Inc. (KPTI)
source: myfinsight.com